Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Metabolic adaptation pilots the differentiation of human hematopoietic cells (scRNA-Seq and CITE-Seq)

ABSTRACT: Metabolic adaptation pilots the differentiation of human hematopoietic cells (scRNA-Seq and CITE-Seq)

PROVIDER: PRJNA1015716 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR26046200_1.fastq.gz	Fastqsanger.gz
	SRR26046200_2.fastq.gz	Fastqsanger.gz
	SRR26046201_1.fastq.gz	Fastqsanger.gz
	SRR26046201_2.fastq.gz	Fastqsanger.gz
	SRR26046202_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 240

Similar Datasets

Taz protects aged hematopoietic stem cells from exhaustion [CITE-seq]

Project description:Taz protects aged hematopoietic stem cells from exhaustion [CITE-seq]

| PRJNA661339 | ENA

Taz protects aged hematopoietic stem cells from exhaustion [CITE-seq]

Project description:We report here the analysis of young and aged hematopoietic stem and progenitor cells (HSPCs) by transcriptional profiling (bulk RNA-Seq, CITE-Seq) and chromatin profiling (ATAC-Seq, scATAC-Seq). We use here a Clca3a1 as a surface marker to further fractionate HSPCs. HSPCs were sorted by flow cytometry. During the staining procedure for flow cytometry, the antibody cocktail also included antibodies labelled with oligos (antibody-derived tags =ADTs) which can later be analyzed by the 10x Chromium controller.

2022-07-14 | GSE157458 | GEO

Metabolic adaptation pilots the differentiation of human hematopoietic cells (scATAC-Seq)

Project description:Metabolic adaptation pilots the differentiation of human hematopoietic cells (scATAC-Seq)

| PRJNA1015713 | ENA

Interleukin-17 governs hypoxic adaptation of injured epithelium [CITE-seq & single-cell RNA-seq]

Project description:Interleukin-17 governs hypoxic adaptation of injured epithelium [CITE-seq & single-cell RNA-seq]

| PRJNA702457 | ENA

Metabolic adaptation pilots the differentiation of human hematopoietic cells (bulk ATAC-Seq)

Project description:Metabolic adaptation pilots the differentiation of human hematopoietic cells (bulk ATAC-Seq)

| PRJNA1015714 | ENA

scRNA-seq of mouse CD45+ aortic cells with CITE-seq and cell Hashing after continuous or alternate diet

Project description:scRNA-seq of mouse CD45+ aortic cells with CITE-seq and cell Hashing after continuous or alternate diet

2024-04-15 | GSE251907 | GEO

scRNA-seq of mouse cardiac CD45+ cells with CITE-seq and cell Hashing

Project description:We performed scRNA-seq and CITE-seq of CD45+ cells extracted from the steady state mouse heart, and at 5 days after myocardial infarction with or without depletion of CCR2+ cells

2022-07-21 | GSE197441 | GEO

scRNA-seq of mouse cardiac CD45+ cells with CITE-seq and cell Hashing II

Project description:We performed scRNA-seq and CITE-seq of CD45+ cells extracted from the steady state mouse heart, and at 5 days after myocardial infarction in wildtype and Trem2 deficient mice

2022-07-21 | GSE197853 | GEO

Metabolic adaptation pilots the differentiation of human hematopoietic cells

Project description:Metabolic adaptation pilots the differentiation of human hematopoietic cells

| PRJNA1015711 | ENA

Titration of 124 antibodies using CITE-Seq on human PBMCs

Project description:Single-cell RNA-sequencing (scRNA-Seq) is widely used to characterize immune cell populations. However, mRNA levels correlate poorly with expression of surface proteins, which are well established to define immune cell types. CITE-Seq (cellular indexing of transcriptomes and epitopes by sequencing) utilizes oligonucleotide-tagged antibodies to simultaneously analyze surface phenotypes and transcriptomes. Considering the high costs of adding surface phenotyping to scRNA-Seq, we aimed to determine which of 188 tested CITE-Seq antibodies can detect their antigens on human peripheral blood mononuclear cells (PBMCs), a commonly interrogated cell population in immunology, and find the optimal concentration for staining. The recommended concentration was optimal for 76 antibodies, whereas staining quality of 7 antibodies improved when the concentration was doubled. 33 and 8 antibodies still worked well when the concentration was reduced to 1/5 or 1/25, respectively. 64 antigens were not detected at any antibody concentration. Optimizing the antibody panel by removing antibodies not able to detect their target antigens and adjusting concentrations of the remaining antibodies could enable a cost reduction of almost 50%. In conclusion, our data are a resource for building an informative and cost-effective panel of CITE-Seq antibodies and use them at their optimal concentrations in future CITE-seq experiments on human PBMCs.

2022-09-18 | GSE213282 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data